Quick verdict: CRM vs IBM in 2026

In this CRM vs IBM stock comparison 2026, Salesforce (CRM) generally holds an operational edge, demonstrating superior growth momentum and robust profitability margins. IBM (International Business Machines Corporation), however, emerges as a compelling value play with a lower P/E and significant implied upside from its discounted cash flow (DCF) valuation. While CRM is the growth and margin leader and the analyst favorite with greater price target upside, IBM offers a potentially deeper value proposition and a slightly higher dividend yield. Not investment advice.

CRM vs IBM: key metrics side by side

Full side-by-side comparison of CRM and IBM across valuation, profitability, growth and analyst sentiment. Data updated 2026-04-30.

CRM vs IBM valuation comparison

When evaluating CRM vs IBM fundamentals and valuation, investors will find distinct characteristics. Salesforce (CRM) currently trades at a P/E ratio of 22.72x, which indicates a higher earnings multiple reflective of its growth profile. Its P/B ratio stands at 2.86x, suggesting its market capitalization is roughly 2.86 times its book value, a relatively conservative multiple for a technology firm. Salesforce’s discounted cash flow (DCF) model indicates a potential upside of +37.2% from its current price of $181.22, implying that even at its current valuation, there’s a margin of safety and potential for appreciation.

International Business Machines (IBM), on the other hand, presents a different valuation landscape. IBM’s P/E ratio is lower at 19.82x, making it relatively cheaper than CRM on an earnings basis. Its P/B ratio is significantly higher at 6.46x, which could suggest a more asset-light model or a historical re-rating of its assets. Crucially, IBM’s DCF analysis points to a substantial upside of +92.7% from its $227.10 price, suggesting a much deeper undervaluation compared to CRM by this intrinsic valuation method. For investors prioritizing a lower earnings multiple and significant DCF potential when considering crm vs ibm valuation 2026, IBM appears to be the more value-oriented stock, despite CRM’s lower price-to-book ratio.

CRM vs IBM growth comparison

In terms of growth, Salesforce (CRM) clearly exhibits stronger momentum compared to IBM. CRM reported a robust year-over-year revenue growth rate of +9.6%, building on its substantial trailing twelve-month revenue of $41.52 billion. This growth trajectory is strongly supported by its dominant market position in cloud-based software and customer relationship management solutions, an expanding sector within the broader technology landscape. The company’s continuous innovation, strategic acquisitions, and its highly scalable subscription-based business model continue to fuel its top-line expansion and contribute significantly to its overall operational efficiency and future potential.

IBM, while a larger enterprise with $67.53 billion in trailing twelve-month revenue, posted a more moderate revenue growth of +7.6% year-over-year. Although this represents solid growth for a company of IBM’s scale and maturity, it lags behind CRM’s accelerated pace. IBM’s growth is largely driven by its strategic focus on hybrid cloud and artificial intelligence (AI) solutions, along with its extensive consulting services. While both companies are crucial players in the technology sector, CRM’s higher revenue growth rate signifies a stronger organic momentum and greater agility in capitalizing on emerging market opportunities, suggesting it has more aggressive forward estimates and a higher growth trajectory in the crm vs ibm earnings growth comparison.

CRM vs IBM profitability

An examination of CRM vs IBM profitability comparison reveals Salesforce (CRM) to be the more efficient and profitable enterprise on several key metrics. CRM boasts an impressive net margin of 17.96% and an even stronger EBITDA margin of 30.64%. These figures highlight Salesforce’s superior ability to convert a significant portion of its revenue into profit and its commendable operational efficiency in managing costs before accounting for interest, taxes, depreciation, and amortization. Furthermore, CRM’s Free Cash Flow (FCF) yield stands at 8.37%, indicating a healthy generation of cash relative to its market capitalization, which is crucial for reinvestment, debt repayment, and potential shareholder returns. The Return on Equity (ROE) for CRM is currently N/A% based on the provided data.

International Business Machines (IBM) demonstrates solid profitability but falls slightly behind CRM in several key metrics. IBM’s net margin is 15.61%, and its EBITDA margin is 23.69%. While these are respectable margins for a technology giant of its stature, they suggest that CRM generally operates with greater efficiency in turning sales into earnings. IBM’s FCF yield is 6.13%, which is positive but lower than CRM’s, implying less free cash generated per dollar of market value. Similar to CRM, the ROE for IBM is also N/A% based on the available data. In summary, CRM generates more cash and is more profitable on both net and EBITDA levels, signaling superior operational performance in this crm vs ibm dividend and margins analysis.

Analyst ratings: CRM vs IBM

Analyst sentiment strongly favors Salesforce (CRM) in the current market landscape. Out of 97 analysts actively covering CRM, a significant 76.3% have issued a “Buy” rating for the stock. The overall consensus among these analysts is a clear “Buy,” which speaks volumes about their confidence in CRM’s future growth prospects, continued market leadership in CRM software, and the ongoing expansion of the cloud software sector. The average price target set by these analysts is $287, implying a substantial upside of +58.4% from CRM’s current trading price of $181.22. This strong endorsement positions CRM favorably for investors looking at crm vs ibm analyst ratings and recommendations.

For International Business Machines (IBM), analyst sentiment is more cautious, yet still largely positive. With coverage from 50 analysts, 44.0% currently recommend a “Buy” for IBM stock. The overall consensus for IBM, however, leans towards a “Hold,” reflecting a more balanced perspective on its near-term outlook and growth drivers. The average analyst price target for IBM is $309.64, suggesting an upside of +36.3% from its current price of $227.10. While IBM still offers considerable potential upside according to analysts, the lower percentage of “Buy” ratings and the “Hold” consensus indicate that the Street views CRM as having stronger immediate growth catalysts and a more compelling short-to-medium term investment case based on price targets.

Should I buy CRM or IBM stock in 2026?

Deciding should I buy CRM or IBM stock 2026 ultimately depends on your individual investment strategy, time horizon, and risk tolerance. For growth-oriented investors, Salesforce (CRM) appears to be the more attractive option. Its superior revenue growth of +9.6%, coupled with higher net and EBITDA margins (17.96% and 30.64% respectively), demonstrates robust operational performance and strong market expansion. Furthermore, the overwhelming analyst consensus of “Buy” and a significant price target upside of +58.4% suggest continued confidence in CRM’s ability to innovate and capture market share in the dynamic cloud computing sector.

Value investors, however, might find International Business Machines (IBM) a more compelling proposition when considering crm vs ibm fundamentals and valuation. IBM trades at a lower P/E ratio of 19.82x compared to CRM’s 22.72x, implying it’s cheaper on an earnings basis. More significantly, its discounted cash flow (DCF) model suggests a remarkable upside of +92.7%, indicating a potentially deep undervaluation by this method. While its revenue growth is slower and its profitability margins are slightly lower than CRM’s, IBM’s strategic focus on high-growth areas like hybrid cloud and AI could unlock substantial long-term value for investors willing to patiently wait for its transformation efforts to fully materialize.

For income-focused investors, the choice between CRM and IBM is relatively straightforward, although both stocks offer very modest yields. IBM provides a dividend yield of 0.03%, which, while minimal, is still three times higher than CRM’s 0.01% yield. Neither stock is a significant income play based purely on dividend income, but IBM holds the slight edge for those prioritizing even a small dividend. Ultimately, your decision on which is the better investment—crm vs ibm stock comparison 2026—should align with your personal financial goals, considering CRM for growth and strong analyst backing, or IBM for potential deep value and a modest dividend. This is not investment advice.

More CRM and IBM comparisons

CRM full stock analysis · IBM full stock analysis · All stock comparisons

FAQ: CRM vs IBM